he Law and Politics of Drug Price Controls and Pharmaceutical InnovationThe Inflation Reduction Act's drug price negotiations are criticized as price fixing rather than true negotiations.
PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing ImpactThe PREVAIL Act is contentious, particularly regarding its potential impact on drug pricing and challenges to pharmaceutical patents.
Life Sciences Masters Panelists Say USPTO's Controversial Anti-Pharma Rules are Unlikely to ProgressThe pharmaceutical industry faces significant scrutiny, yet recent proposals damaging to it are unlikely to advance.
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study SponsorsThe public disclosure of human clinical trials may potentially lead to the invalidation of pharmaceutical patents, causing concerns for pharmaceutical innovators.